CTRI/2019/02/017646已完成3 期
Efficacy of L-carnosine as an add on treatment for negative and cognitive symptoms in schizophrenia - A randomized double blind placebo controlled study - LCARS
Brio Bliss life science pvtltd0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients aged 18-40 years.
- •2.ICD -10 diagnosis of schizophrenia.
- •3.Willing to participate in the study
- •4.Education 9th std and above
- •5.Cognitive deficit of 15% on one domain of NIMHANS battery.
- •6.SANS total score > 60
排除标准
- •1.Patients who are uncooperative due to the severity of the illness.
- •2.Existence of serious medical/neurological disorder, known allergic to L-carnosine.
- •3.Patients with mental retardation, H/O drug or alcohol dependence.
- •4.Women who were currently pregnant /breastfeeding.
- •5.Not consenting to participate in the study.
研究者
相似试验
已完成
不适用
Carnosine in the treatment of OCDObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201604201556N88Tehran University of Medical Sciences50
已完成
3 期
carnosine in patients with schizophreniaschizophrenia.schizophreniaIRCT201504211556N75Tehran University of Medical Sciences50
已完成
不适用
Effects Of Carnosine On Autismautism disordersAutism Disorder.IRCT2016061711689N4Deputy Of Research And Technology Of Tabriz University Of Medical Science, Nutritional Science Resea50
已完成
不适用
The effect of carnosine supplementation in type 2 diabetic patientsType 2 Diabetes.Non-insulin-dependent diabetes mellitusIRCT2016011211689N2Deputy of research and technology of Tabriz university of medical science44
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50